A preliminary study found that adults with type 2 diabetes and a moderate or high risk of cardiovascular disease were less likely to experience a serious cardiovascular event when taking low-dose ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will incubate local biotechs starting with Puhe BioPharma and Youngen Technology.

BERLIN, Nov 23 (Reuters) - German pharma company Bayer (BAYGn.DE), opens new tab reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

FRANKFURT, Nov 24 (Reuters) - Shares in Bayer (BAYGn.DE), opens new tab jumped more than 8% on Monday after initial clinical trial results turned around the fortunes of a key cardiovascular drug that ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bayer reported positive results in a late-stage trial of an experimental stroke prevention medicine, sending ...

Novo Nordisk NVO announced that it has submitted a regulatory filing seeking label expansion for a higher dose of its blockbuster obesity drug, Wegovy (injectable semaglutide). The FDA filing seeks ...

Let's talk about practice. As we mentioned this morning, there were no fewer than 14 forwards at practice. The uncertainty surrounding Alexandre Texier (who has just arrived) and Jared Davidson (who ...

UMBRELLA IN MY FULL FORECAST. THANK YOU MARY ELLEN. TODAY, HUNDREDS OF NONPROFITS AND ORGANIZATIONS THAT SERVE THE SUSQUEHANNA VALLEY ARE ASKING FOR YOUR DONATIONS AS PART OF THE LARGEST SINGLE DAY ...